Dyne Therapeutics, Inc. DYN Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $100.89M+5.7% | $95.43M-1.8% | $97.22M-2.0% | $99.24M-6.8% | $106.45M+30.1% | ||
| $24.39M+17.8% | $20.7M+24.1% | $16.67M+0.7% | $16.56M+4.0% | $15.93M+4.1% | ||
| $125.28M+7.9% | $116.13M+2.0% | $113.89M-1.6% | $115.79M-5.4% | $122.37M+26.0% | ||
| $125.28M+7.9% | $116.13M+2.0% | $113.89M-1.6% | $115.79M-5.4% | $122.37M+26.0% | ||
| -$125.28M-7.9% | -$116.13M-2.0% | -$113.89M+1.6% | -$115.79M+5.4% | -$122.37M-26.0% | ||
| $4.2M+31.6% | $3.19M+10.0% | $2.9M+2,989% | $94K— | $0— | ||
| $8.76M+14.4% | $7.66M-9.7% | $8.48M+27.9% | $6.63M-6.7% | $7.1M-6.5% | ||
| $4.42M+5.9% | $4.17M-28.7% | $5.85M+18.6% | $4.93M-29.6% | $7.01M-7.3% | ||
| -$120.85M-7.9% | -$111.96M-3.6% | -$108.04M+2.5% | -$110.86M+3.9% | -$115.36M-28.8% | ||
| -$0.730.0% | -$0.73+3.9% | -$0.76+21.6% | -$0.97+7.6% | -$1.05-19.3% | ||
| -$0.730.0% | -$0.73+3.9% | -$0.76+21.6% | -$0.97+7.6% | -$1.05-19.3% | ||
| -$121.47M-8.5% | -$111.98M-3.9% | -$107.8M+2.8% | -$110.85M+3.7% | -$115.13M-27.9% | ||
| $8.76M+14.4% | $7.66M-9.7% | $8.48M+27.9% | $6.63M-6.7% | $7.1M-6.5% | ||
| -$612K— | $0-100% | $244K+2,118% | $11K-95.3% | $235K— | ||
| $4.42M+5.9% | $4.17M-28.7% | $5.85M+18.6% | $4.93M-29.6% | $7.01M-7.3% | ||
| -$133K+54.0% | -$289K-204% | $279K+117% | -$1.6M-1,694% | -$89K-242% | ||
| 165M+28.5% | 128.4M-9.4% | 141.8M+24.5% | 113.9M+3.6% | 109.9M+16.7% | ||
| 165M+28.5% | 128.4M-9.4% | 141.8M+24.5% | 113.9M+3.6% | 109.9M+16.7% | ||
| -$125.28M-7.9% | -$116.13M-2.0% | -$113.89M+1.6% | -$115.79M+5.4% | -$122.37M-26.0% | ||
| -$124.73M-7.9% | -$115.61M-2.0% | -$113.39M+1.6% | -$115.29M+5.4% | -$121.87M-26.1% | ||
| -$124.73M-7.9% | -$115.61M-2.0% | -$113.39M+1.6% | -$115.29M+5.4% | -$121.87M-26.1% | ||
| -$125.28M-7.9% | -$116.13M-2.0% | -$113.89M+1.6% | -$115.79M+5.4% | -$122.37M-26.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dyne Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Dyne Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.